Your browser doesn't support javascript.
loading
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
Pruneri, Giancarlo; Gray, Kathryn P; Vingiani, Andrea; Viale, Giuseppe; Curigliano, Giuseppe; Criscitiello, Carmen; Láng, István; Ruhstaller, Thomas; Gianni, Lorenzo; Goldhirsch, Aron; Kammler, Roswitha; Price, Karen N; Cancello, Giuseppe; Munzone, Elisabetta; Gelber, Richard D; Regan, Meredith M; Colleoni, Marco.
Affiliation
  • Pruneri G; IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. giancarlo.pruneri@ieo.it.
  • Gray KP; University of Milan, Milan, Italy. giancarlo.pruneri@ieo.it.
  • Vingiani A; International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA.
  • Viale G; Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Curigliano G; IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
  • Criscitiello C; University of Milan, Milan, Italy.
  • Láng I; IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
  • Ruhstaller T; University of Milan, Milan, Italy.
  • Gianni L; Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
  • Goldhirsch A; Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
  • Kammler R; National Institute of Oncology, Ráth György u. 7/9, Budapest, 1122, Hungary.
  • Price KN; Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland.
  • Cancello G; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Munzone E; Divisione di Oncologia, Ospedale degli Infermi, Viale Settembrini 2, 47923, Rimini, Italy.
  • Gelber RD; Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
  • Regan MM; International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland.
  • Colleoni M; International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA.
Breast Cancer Res Treat ; 158(2): 323-31, 2016 07.
Article in En | MEDLINE | ID: mdl-27372069
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Methotrexate / Lymphocytes, Tumor-Infiltrating / Cyclophosphamide / Triple Negative Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2016 Type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Methotrexate / Lymphocytes, Tumor-Infiltrating / Cyclophosphamide / Triple Negative Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2016 Type: Article Affiliation country: Italy